Naproxen Accord

Naproxen, the active ingredient in Naproxen Accord, is a nonsteroidal anti-inflammatory drug presented as an oral tablet for oral use. It relieves mild to moderate pain, reduces inflammation, and lowers fever in adults.

GNH USA supplies Naproxen Accord as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Naproxen is an NSAID that reduces inflammation and pain by inhibiting cyclooxygenase enzymes.

- Mild to moderate pain: provides analgesic relief for everyday aches. - Arthritis (e.g., osteoarthritis, rheumatoid arthritis): decreases joint inflammation and improves mobility. - Dysmenorrhea: alleviates menstrual cramps. - Fever: reduces elevated body temperature.

Common side effects are generally mild and reversible.

Common Side Effects: - Gastrointestinal upset: nausea, dyspepsia, or abdominal discomfort. - Headache: mild to moderate intensity. - Dizziness or vertigo. - Mild skin rash or itching. - Elevated liver enzymes (asymptomatic).

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding. - Cardiovascular events such as myocardial infarction or stroke. - Acute renal impairment or failure. - Severe skin reactions (e.g., Stevens‑Johnson syndrome). - Hepatic injury or hepatitis. - Anaphylaxis or severe hypersensitivity reactions.

Before initiating therapy, consider the following safety measures.

- Assess gastrointestinal risk: evaluate history of ulcers or bleeding before use. - Monitor renal function: avoid in patients with severe renal impairment. - Avoid in known hypersensitivity to NSAIDs or aspirin. - Use caution in cardiovascular disease: weigh thrombotic risk versus benefit. - Store at room temperature: keep in the original pack, protect from moisture and heat.

Naproxen can interact with several drug classes; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of bleeding. - Selective serotonin reuptake inhibitors (SSRIs): heightened gastrointestinal bleeding. - Lithium: naproxen may raise lithium serum concentrations. - Methotrexate: reduced clearance leading to toxicity. - ACE inhibitors or ARBs: possible impairment of renal function.

Moderate Interactions (Monitor Closely): - Diuretics: may affect renal handling of fluids and electrolytes. - Beta‑blockers: potential reduction in antihypertensive effect. - Corticosteroids: additive risk of gastrointestinal ulceration.